Related Experiment Videos
Evaluation of morbidity among human T lymphotropic virus type 1 carriers in Miyazaki, Japan
S O Stuver1, N Tachibana, A Okayama
1Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, 02115, USA.
Abstract:
Morbidity associated with human T lymphotropic virus type I (HTLV-I) infection was investigated in a Japanese population within an area in which HTLV-I infection is endemic. Of 1824 subjects enrolled in the Miyazaki Cohort Study between November 1984 and May 1991, 500 (27.4%) were seropositive for HTLV-I antibodies. As expected from previous studies, HTLV-I positively appeared to be associated with baseline history of anemia (adjusted odds ratio [OR]= 1.3; 95% confidence interval [CI]= 0.99-1.7) and kidney disease (OR=1.6; 95% CI= 0.91-2.9); a positive association also was noted for asthma in men (OR=3.4; 95% CI=1.2-9.8). Unanticipated findings included a relationship between HTLV-I infection and cardiac disease history (OR=1.4; 95% CI=0.94-2.2; HTLV-I carriers also were more likely to have an abnormal electrocardiogram at baseline (OR=1.5; 95% CI=1.2-1.9). Furthermore, an apparent protective effect for ulcers (OR=0.62; 95% CI=0.40-0.95) and diabetes (OR=0.49;95% CI=0.22-1.1) was observed. HTLV-I infection may modify the risk of specific disease outcomes by altering host immune function.
Insights
Human T lymphotropic virus type I (HTLV-I) infection in Japan is linked to increased risks of anemia, kidney disease, and asthma in men. HTLV-I carriers also showed higher rates of cardiac issues, but a potential protective effect against ulcers and diabetes was observed.
Area of Science:
- Infectious Diseases
- Epidemiology
- Immunology
Background:
- Human T lymphotropic virus type I (HTLV-I) is endemic in certain populations.
- Understanding HTLV-I associated morbidity is crucial for public health.
- Previous studies have indicated links between HTLV-I and specific diseases.
Purpose of the Study:
- To investigate the association between HTLV-I infection and various morbidities in a Japanese cohort.
- To identify both expected and unexpected health outcomes in HTLV-I seropositive individuals.
- To explore the potential impact of HTLV-I on host immune function and disease risk.
Main Methods:
- A prospective cohort study involving 1824 Japanese subjects.
- Serological testing for HTLV-I antibodies to identify infected individuals.
- Statistical analysis, including odds ratios and confidence intervals, to assess disease associations.
Main Results:
- HTLV-I infection was associated with anemia (OR=1.3) and kidney disease (OR=1.6).
- A significant association was found between HTLV-I and asthma in men (OR=3.4).
- HTLV-I carriers showed increased cardiac disease history (OR=1.4) and abnormal ECGs (OR=1.5), but a protective effect against ulcers (OR=0.62) and diabetes (OR=0.49).
Conclusions:
- HTLV-I infection is associated with a range of morbidities, including anemia, kidney disease, asthma, and cardiac conditions.
- HTLV-I may influence disease risk through modulation of the host immune system.
- Further research is needed to elucidate the mechanisms behind these observed associations.